Armenia vs Burkina Faso: Treatment success rate for patients treated for MDR-TB
Armenia
68.0%
in 2022
Burkina Faso
69.0%
in 2022
Armenia rank
104th
Burkina Faso rank
101st
Treatment success rate for patients treated for MDR-TB over time
- Armenia
- Burkina Faso
How they compare
Burkina Faso currently reports 69.0% against 68.0% in Armenia, a difference of 1.0%.
The two have swapped places 5 times across 16 shared years of data; in 2007 it was Armenia ahead.
Armenia ranks 104th and Burkina Faso ranks 101st of 163 countries.
Burkina Faso has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Armenia | Burkina Faso | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.0% | 55.0% | 2.0% | Burkina Faso |
| 2010s | 48.2% | 65.3% | 17.1% | Burkina Faso |
| 2020s | 67.3% | 68.0% | 0.7% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Armenia or Burkina Faso?
- Burkina Faso, at 69.0% against 68.0% in Armenia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Armenia and Burkina Faso?
- 1.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Armenia and Burkina Faso?
- 16 years are reported by both, from 2007 to 2022.
- How do Armenia and Burkina Faso rank globally for treatment success rate for patients treated for mdr-tb?
- Armenia ranks 104th and Burkina Faso ranks 101st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.